Eman Badr: From Platelets to Precision Oncology
Eman Badr, Associate Professor of Zewail City of Science and Technology, shared a post on LinkedIn about a recent article she and her colleagues co-authored published in Discver Oncology, adding:
“A new paper from our group is now out in Discover Oncology:
‘Integrative analysis of tumor-educated platelets for stage-specific diagnosis, prognosis, and therapy in ovarian cancer’
In this study, we explored tumor-educated platelet mRNAs as a non-invasive source for ovarian cancer biomarker discovery.
We used an integrative computational framework that included differential expression analysis, machine learning, survival analysis, pathway enrichment, and in silico drug screening.
The study identified stage-specific candidate biomarkers and potential drug repurposing opportunities in ovarian cancer.
This work is special as it reflects the effort and persistence of my students, especially Shaimaa Gamal , who led this project as part of her MSc work, together with Mostafa Ibrahim.
I am very proud of them for their hard work, patience, and commitment throughout this journey.”
Title: Integrative analysis of tumor-educated platelets for stage-specific diagnosis, prognosis, and therapy in ovarian cancer
Authors: Shaimaa Gamal Gahin, Mostafa S. Ibrahim, Eman Badr
Stay updated on all scientific advances with Hemostasis Today.
-
May 26, 2026, 07:12Jenish Christin: The Clot Buster That Buys Time in Critical Moments
-
May 26, 2026, 06:43Francisco Epelde: Cardiac Lymphatic System as an Active Regulator of Myocardial Homeostasis
-
May 26, 2026, 06:39Reza Shojaei: How Neurology is Reshaping the Plasma Market?
-
May 26, 2026, 05:4779th World Health Assembly Approves Global Equity Resolution – EHC
-
May 26, 2026, 03:02Spelile Mutupira: Process of Blood Clotting After Injury
-
May 26, 2026, 03:00Clinton Otwori: Which Blood Product Do Healthcare Workers Most Commonly Misunderstand in Practice?
-
May 26, 2026, 02:58Toriqul Islam: EDTA-Induced Pseudothrombocytopenia
-
May 26, 2026, 02:34James O’Donnell Secures 2 Million Euros for a New Programme on The Irish ABO and Coagulation Study – RCSI
-
May 26, 2026, 02:26Joseph R. Shaw: Join The Annual CanVECTOR National Thrombosis Seminar on Precision in DOAC Reversal